Free Trial

Castleark Management LLC Makes New $17.67 Million Investment in DocuSign, Inc. (NASDAQ:DOCU)

DocuSign logo with Computer and Technology background

Castleark Management LLC acquired a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 196,450 shares of the company's stock, valued at approximately $17,669,000. DocuSign makes up about 0.6% of Castleark Management LLC's portfolio, making the stock its 28th biggest position. Castleark Management LLC owned approximately 0.10% of DocuSign at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. FMR LLC boosted its stake in DocuSign by 178.2% during the fourth quarter. FMR LLC now owns 6,101,024 shares of the company's stock worth $548,726,000 after acquiring an additional 3,908,139 shares in the last quarter. Invesco Ltd. increased its stake in shares of DocuSign by 283.9% during the fourth quarter. Invesco Ltd. now owns 3,447,275 shares of the company's stock valued at $310,048,000 after purchasing an additional 2,549,310 shares in the last quarter. Norges Bank purchased a new position in shares of DocuSign during the fourth quarter valued at approximately $223,196,000. Arrowstreet Capital Limited Partnership boosted its position in shares of DocuSign by 201.6% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,158,311 shares of the company's stock worth $194,118,000 after purchasing an additional 1,442,639 shares in the last quarter. Finally, Jericho Capital Asset Management L.P. boosted its position in shares of DocuSign by 34.0% in the 4th quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock worth $427,642,000 after purchasing an additional 1,205,500 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

DocuSign Stock Down 2.2%

DOCU traded down $1.92 during midday trading on Monday, hitting $84.61. 1,338,670 shares of the company traded hands, compared to its average volume of 2,769,233. The company's 50-day moving average is $81.76 and its 200 day moving average is $85.81. The firm has a market capitalization of $17.13 billion, a PE ratio of 17.45, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. During the same quarter in the prior year, the firm earned $0.76 earnings per share. The firm's revenue for the quarter was up 9.0% compared to the same quarter last year. On average, sell-side analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Jefferies Financial Group reduced their price objective on DocuSign from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, March 31st. Wedbush restated a "neutral" rating and set a $100.00 price target on shares of DocuSign in a report on Friday, March 14th. Wells Fargo & Company lowered their price target on DocuSign from $73.00 to $65.00 and set an "underweight" rating for the company in a research report on Tuesday, April 22nd. William Blair reiterated an "outperform" rating on shares of DocuSign in a research note on Monday, April 21st. Finally, Robert W. Baird set a $93.00 price objective on shares of DocuSign in a research report on Friday, March 14th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, DocuSign currently has an average rating of "Hold" and an average price target of $92.46.

Check Out Our Latest Research Report on DocuSign

Insider Transactions at DocuSign

In other DocuSign news, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now directly owns 8,270 shares in the company, valued at approximately $722,880.70. This trade represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $76.09, for a total transaction of $608,720.00. Following the transaction, the chief financial officer now owns 86,156 shares in the company, valued at $6,555,610.04. This represents a 8.50% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 47,851 shares of company stock worth $3,912,239 in the last ninety days. Insiders own 1.01% of the company's stock.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines